JDP is developing a first-in-class injectable therapy for hospital use for the treatment of acute allergic reactions, with no competition.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free